The Dow Jones index closed higher by around 50 points on Thursday. Insiders’ stock transactions signify their confidence or concern about the company’s potential, an aspect investors and traders eyeing penny stocks should consider in their strategies.
Below is a glimpse of some recent significant insider activities concerning penny stocks. For further details, explore Benzinga’s insider transactions platform.
Dalrada Financial
- The Buy: Dalrada Financial Corporation DFCO Chief Executive Officer Brian Bonar obtained 52,600 shares at an average price of $0.22, amounting to approximately $11,831.
- Stock Movement: The company’s stock depreciated by roughly 16% over the past month.
- Dalrada Financial’s Business: Dalrada Financial Corp offers financial, insurance, benefit, and business process outsourcing products and services to firms.
Research Frontiers
- The Acquisition: Research Frontiers Incorporated REFR Director Darryl Daigle purchased 1,000 shares at an average price of $1.00, amounting to about $1,000.
- Company Update: On Nov. 2, Research Frontiers reported a reduced third-quarter loss.
- Research Frontiers’ Focus: Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light.
DBV Technologies
- The Purchase: DBV Technologies S.A. DBVT Director Adora Ndu bought 1,825 shares at an average price of $0.89, entailing an expenditure of around $1,624.
- Company Update: On Nov. 10, DBV Technologies disclosed 2-year results from the ongoing Phase 3 open-label extension to the EPITOPE trial (EPOPEX) of Viaskin™ peanut in toddlers.
- DBV Technologies’ Mission: DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on transforming the field of immunotherapy through the development of a pioneering technology platform called Viaskin.
Make sure to explore our premarket coverage here
